| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S A Treseder, M Jackson, P Jenne. The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates. British journal of pharmacology. vol 129. issue 7. 2000-05-25. PMID:10742291. |
rather, they strengthen the argument for the importance of endogenous dopaminergic tone in the motor actions of dopamine agonists. |
2000-05-25 |
2023-08-12 |
Not clear |
| J M Brown, G R Hanson, A E Fleckenstei. Methamphetamine rapidly decreases vesicular dopamine uptake. Journal of neurochemistry. vol 74. issue 5. 2000-05-25. PMID:10800970. |
moreover, recent evidence suggests that increases in cytoplasmic dopamine levels, perhaps attributable to changes in vesicular monoamine transporter function, contribute to methamphetamine-induced dopaminergic deficits. |
2000-05-25 |
2023-08-12 |
Not clear |
| E Isovich, M J Mijnster, G Flügge, E Fuch. Chronic psychosocial stress reduces the density of dopamine transporters. The European journal of neuroscience. vol 12. issue 3. 2000-05-22. PMID:10762338. |
therefore, the aim of the current study was to investigate the effect of chronic psychosocial stress on the dopamine transporter, which is an important component in the regulation of dopaminergic neurotransmission. |
2000-05-22 |
2023-08-12 |
Not clear |
| M Laruell. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain research. Brain research reviews. vol 31. issue 2-3. 2000-05-17. PMID:10719165. |
sensitization of mesolimbic dopamine systems has been postulated by several authors to underlie the development of dopaminergic abnormalities associated with schizophrenia. |
2000-05-17 |
2023-08-12 |
Not clear |
| M Laruell. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain research. Brain research reviews. vol 31. issue 2-3. 2000-05-17. PMID:10719165. |
based on the preclinical evidence that dopamine projection to the prefrontal cortex acts as a buffer that oppose the development of sensitization in subcortical dopamine projections, we propose that, in schizophrenia, neurodevelopmental abnormalities of prefrontal dopaminergic systems might result in a state of enhanced vulnerability to sensitization during late adolescence and early adulthood. |
2000-05-17 |
2023-08-12 |
Not clear |
| P Damier, L Tremblay, J Féger, E C Hirsc. [Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)]. Revue neurologique. vol 156. issue 3. 2000-05-16. PMID:10740093. |
the results of recent experiments have given rise to several different hypothesis for the mechanisms involved in priming: the role of internalization of dopamine receptors after administration of dopaminergic drugs; change in the distribution of d3 dopamine receptor; changes in the expression of peptides (substance p, enkephalin) in efferent neurons of the striatum; and reorganization of connections at the level of the dopaminergic neurons and their target tissue. |
2000-05-16 |
2023-08-12 |
monkey |
| A Pope-Coleman, J P Tinker, J S Schneide. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys. Synapse (New York, N.Y.). vol 36. issue 2. 2000-05-12. PMID:10767059. |
these results show that gm1 treatment can partially restore striatal dopaminergic terminals and partially reverse postsynaptic changes in dopamine receptors in a nonhuman primate model of parkinsonism. |
2000-05-12 |
2023-08-12 |
monkey |
| D Joel, I Weine. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. vol 96. issue 3. 2000-04-27. PMID:10717427. |
(3) projections from functionally corresponding subdivisions of the striatum, pallidum and subthalamic nucleus to the dopaminergic system overlap, but the specific targets (dopamine cells, dopamine dendrites, gaba cells) of these projections differ. |
2000-04-27 |
2023-08-12 |
rat |
| D Joel, I Weine. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. vol 96. issue 3. 2000-04-27. PMID:10717427. |
(3) in rats, patch- and matrix-projecting dopamine cells are organized in spatially, morphologically, histochemically and hodologically distinct ventral and dorsal tiers, while in primates there is no (bi)division of the dopaminergic system that results in two areas which have all the characteristics of the two tiers in rats. |
2000-04-27 |
2023-08-12 |
rat |
| A H Schapir. Sleep attacks (sleep episodes) with pergolide. Lancet (London, England). vol 355. issue 9212. 2000-04-27. PMID:10776749. |
increased sedation, somnolence, and sleep episodes seem to occur with several, if not all, dopamine agonists and dopaminergic treatment. |
2000-04-27 |
2023-08-12 |
Not clear |
| X Zhou, W Zhang, T Ba. [Expression of glial cells line-derived neurotrophic factor in the central nervous system of rat]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao. vol 29. issue 3. 2000-04-25. PMID:10684095. |
glial cell line-derived neurotrophic factor (gdnf) iss a distant member of the transforming growth factor-beta, originally isolated by virtue of its ability to induce dopamine uptake and cell survival in cultures of embryonic ventral midbrain dopaminergic neurons, and more recently it has been shown to be a potent neurotrophic factor for motor neurons. |
2000-04-25 |
2023-08-12 |
rat |
| M Santiago, E R Matarredona, L Granero, J Cano, A Machad. Neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals. Brain research. vol 858. issue 1. 2000-04-25. PMID:10700592. |
neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals. |
2000-04-25 |
2023-08-12 |
Not clear |
| V Coiro, R Volpi, S Cataldo, L Capretti, G Caffarri, S Pilla, P Chioder. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. vol 48. issue 2. 2000-04-24. PMID:10736973. |
in light of the inhibitory effect of somatostatin and dopamine on tsh secretion, we examined whether this condition is caused by glucocorticoids through an increased hypothalamic somatostatinergic and/or dopaminergic inhibitory control of tsh. |
2000-04-24 |
2023-08-12 |
Not clear |
| C O Jaliffa, F F Lacoste, D W Llomovatte, M I Sarmiento, R E Rosenstei. Dopamine decreases melatonin content in golden hamster retina. The Journal of pharmacology and experimental therapeutics. vol 293. issue 1. 2000-04-21. PMID:10734157. |
the effect of dopamine was reversed by spiperone and clozapine (selective antagonists for d(2) and for d(4)/d(2) dopaminergic receptors, respectively) but not by sch 23390 (a selective d(1) dopamine receptor antagonist). |
2000-04-21 |
2023-08-12 |
Not clear |
| C O Jaliffa, F F Lacoste, D W Llomovatte, M I Sarmiento, R E Rosenstei. Dopamine decreases melatonin content in golden hamster retina. The Journal of pharmacology and experimental therapeutics. vol 293. issue 1. 2000-04-21. PMID:10734157. |
retinal dopaminergic turnover rate (assessed as the ratio of 3,4-dihydroxyphenylacetic acid to dopamine) was significantly higher at midday than at midnight. |
2000-04-21 |
2023-08-12 |
Not clear |
| S C Sealfo. Dopamine receptors and locomotor responses: molecular aspects. Annals of neurology. vol 47. issue 4 Suppl 1. 2000-04-21. PMID:10762128. |
the current understanding of the molecular, cellular and systemic consequences of dopaminergic activation of the different cloned dopamine receptors is reviewed. |
2000-04-21 |
2023-08-12 |
Not clear |
| F Calon, R Grondin, M Morissette, M Goulet, P J Blanchet, T Di Paolo, P J Bédar. Molecular basis of levodopa-induced dyskinesias. Annals of neurology. vol 47. issue 4 Suppl 1. 2000-04-21. PMID:10762134. |
biochemical analysis of the brains revealed several alterations in dopamine receptor-binding and messenger rna message following denervation and dopaminergic treatment, but none that clearly correlated with the presence of dyskinesias. |
2000-04-21 |
2023-08-12 |
monkey |
| D J Brooks, P Piccini, N Turjanski, M Samue. Neuroimaging of dyskinesia. Annals of neurology. vol 47. issue 4 Suppl 1. 2000-04-21. PMID:10762143. |
dyskinesias are observed in the majority of parkinson's disease (pd) patients who have been chronically exposed to levodopa, and these may result from supersensitivity of postsynaptic striatal dopamine d1 and d2 receptors following loss of nigral dopaminergic projections. |
2000-04-21 |
2023-08-12 |
Not clear |
| C W Olanow, J A Obes. Preventing levodopa-induced dyskinesias. Annals of neurology. vol 47. issue 4 Suppl 1. 2000-04-21. PMID:10762145. |
these could include the use of dopaminergic agents with a relatively long half-life, neuroprotective therapies that prevent the loss of dopamine neurons, and transplantation strategies or trophic factors that increase the number of dopamine terminals capable of buffering fluctuations in striatal dopamine. |
2000-04-21 |
2023-08-12 |
Not clear |
| A U Trendelenburg, R Bültman. P2 receptor-mediated inhibition of dopamine release in rat neostriatum. Neuroscience. vol 96. issue 2. 2000-04-20. PMID:10683564. |
suramin, in addition, partly prevents the attenuation of dopamine release evoked by a single stimulus that follows a brief train of high-frequency pulses.these findings suggest the existence of release-inhibiting p2 receptors on dopaminergic nerve terminals and indicate that dopaminergic transmission in rat neostriatum might be modulated by an endogenous p2 receptor ligand, presumably atp. |
2000-04-20 |
2023-08-12 |
rat |